Clinical Validation of a Urinary Exosome Gene Signature in Men Presenting for Suspicion of Prostate Cancer
NCT02702856 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2000
Last updated 2016-03-09
Summary
Validate a non-DRE exosome gene expression test, with an NPV \>/= 90% certainty, will exclude the presence of high gleason grade/ score (\>/=7) prostate cancer in a prostate needle biopsy.
Conditions
Interventions
- OTHER
-
ExoIntelliScore Prostate
Sponsors & Collaborators
-
Exosome Diagnostics, Inc.
lead INDUSTRY
Principal Investigators
-
Roger Tun · Exosome Diagnostics, Inc.
Eligibility
- Min Age
- 50 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2014-05-31
- Primary Completion
- 2015-04-30
- Completion
- 2015-06-30
More Related Trials
-
Prostate Cancer Evaluation of TaRgets in Genito Urinary Screening Program
NCT01786031 ·Status: COMPLETED ·Phase: NA
-
Clinical Evaluation of the PROGENSA(Registered Trademark) Prostate Cancer Gene 3 (PCA3) Assay in Men With a Previous Negative Biopsy Result
NCT01024959 ·Status: COMPLETED ·Phase: NA
-
Targeted Prostate Biopsy Using a Novel MRI-Ultrasound Fusion Device
NCT02524860 ·Status: UNKNOWN ·Phase: NA
-
Clinical Use of 68Ga PSMA-11 PET/CT in Diagnosing, Staging and Restaging Prostate Cancer
NCT05002465 ·Status: NO_LONGER_AVAILABLE
-
Evaluation of Prostate Specific Membrane Antigen Positron Emission Tomography-Computed Tomography in Active Surveillance for Prostate CancEr
NCT05948657 ·Status: RECRUITING ·Phase: NA
-
Medical Economics of Urinary PCA3 Test for Prostate Cancer Diagnosis
NCT01632930 ·Status: COMPLETED ·Phase: NA
-
Prostasomes as Diagnostic Tool for Prostate Cancer Detection
NCT03694483 ·Status: SUSPENDED
-
A Pilot Trial Using BR55 Ultrasound Contrast Agent in the Assessment of Prostate Cancer
NCT02142608 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Clinical Utility of MyProstateScore 2.0 P2
NCT05910697 ·Status: TERMINATED ·Phase: NA
-
Immuno-molecular Approaches for Non-invasive Diagnosis of Prostate Cancer
NCT04702633 ·Status: COMPLETED
-
Research on the Application of 68Ga-PSMA-CYC PET Imaging in the Diagnosis, Staging, and Restaging of Prostate Cancer
NCT07056790 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Precision-Based Genomics in Prostate Cancer
NCT04706663 ·Status: RECRUITING
-
Multicentric Comparative Prospective Study of the Benefits and Risks of Biopsy Prostate Using Transrectal or Transperineal Procedure for the Prostate Cancer Diagnostic
NCT05763355 ·Status: COMPLETED ·Phase: NA
-
GUidance In Prostate Cancer DEtection With 18F-PSMA-1007-PET/MRI and Targeted Biopsies
NCT07258056 ·Status: RECRUITING ·Phase: NA
-
Correlation Between SUV on 68Ga-HBED-CC-PSMA and Gleason Score in Prostate Cancer
NCT02796807 ·Status: COMPLETED ·Phase: PHASE2
-
68 Ga-PSMA for High Risk Prostate Cancer
NCT04614363 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
MRI Screening in Men at High Risk of Developing Prostate Cancer
NCT05608694 ·Status: RECRUITING ·Phase: NA
-
Comparing Standard of Care Biopsy System to a Novel Biopsy Needle System by Computational Pathologic Analysis
NCT06830265 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Image-Guided (68Ga-PSMA-11 PET/CT) Prostate Biopsy for the Diagnosis of Prostate Cancer in Men With Prior Negative/Inconclusive Biopsy
NCT05160597 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Multi-Center Trial of High-resolution Transrectal Ultrasound Versus Standard Low-resolution Transrectal Ultrasound for the Identification of Clinically Significant Prostate Cancer
NCT02079025 ·Status: COMPLETED ·Phase: NA
-
Detection of Clinically Significant Prostate Cancer Using a Urinary Multimarker Sensor
NCT04825002 ·Status: UNKNOWN ·Phase: NA
-
PRostate Cancer Plasma Integrative Multi-modal Evaluation
NCT06981377 ·Status: RECRUITING
-
Clinical Utility of ClarityDX Prostate
NCT06678828 ·Status: RECRUITING ·Phase: NA
-
Prognostic Study of Via Dynamic Change of PCA3 mRNA in Drainage Fluid After Radical Prostatectomy
NCT06707961 ·Status: NOT_YET_RECRUITING
-
Assessing Circulating Tumor Cell as a Biomarker for Prostate Cancer Detection in Patients With Gray Zone PSA Level
NCT03488706 ·Status: UNKNOWN